top of page

OUR RESEARCH APPROACH

Discover. Develop. Deliver.
We are taking a holistic approach towards developing effective treatments for UBA5 with a focus on gene therapy as our first solution. We will be operating like a lean startup, meaning we will be fast, efficient and cross-functional. 

CURE DEVELOPMENT

RESEARCH ENABLERS

ANIMAL DISEASE MODELS

PATIENT-DERIVED MODELS

PATIENT DATA

BASIC RESEARCH

Anchor 1

OUR SCIENCE PARTNERS

Here are a list of our science partners and the research and support they’ve given to this foundation. Click through to learn more.

UMASS CHAN

MEDICAL SCHOOL

GENE REPLACEMENT THERAPY

Developing a gene therapy (AAV9) to correct UBA5 deficiency. This preclinical development will lead to an investigational new drug application to the FDA.

The top two AAV9 vectors expressing UBA5 have been identified and are currently undergoing efficiency testing before proceeding to toxicology. 

Grant opportunities

More information to come soon

Raiden Science Foundation Logo R only-02.png

We are racing against time to develop a life-saving treatment for UBA5 Disorder.

bottom of page